Remote Strategic Account Liaison - Rare Neurology (ALS)

Otsuka America Pharmaceutical Inc.; Denver (CO); Remote; USD 158,000 - 252,000; Full time

Job summary

Otsuka America Pharmaceutical Inc. is seeking a Strategic Account Liaison to support the launch and growth of its Rare Neurology Franchise, focusing on ALS centers, providers, and key stakeholders.

You will communicate complex clinical data and guide patients through access programs to enable timely therapy initiation. The role emphasizes cross-functional collaboration, market access navigation, and education on disease pathways, with initial focus on FUS-ALS and related therapies, while

Qualifications

• Experience in understanding complex disease states and ability to learn and articulate complex clinical data.
• Educate on disease state awareness, screening, and diagnostic pathways.
• Identify and maintain relationships with HCPs and Key Opinion Leaders as a credible resource.
• Create positive prescribing experiences through access and patient support programs.
• Participate in conferences and scientific meetings to educate on rare neurology.

Responsibilities

• Educate clinicians on disease state and screening pathways, instilling urgency to treat.
• Identify and maintain relationships with HCPs and KOLs as credible resources.
• Drive prescribing through access and patient support programs.
• Participate in conferences to educate on rare neurology disease states and treatments.

Skills

Clinical acumen

Customer engagement

KOL engagement

Education on disease state

Conference education

Strategic account planning

Market access navigation

Hospital purchasing

Cross-functional collaboration

Therapy onboarding

Education

Bachelor’s Degree

Advanced clinical degrees prioritized

Job description

Otsuka America Pharmaceutical Inc. is seeking a Strategic Account Liaison to support the launch and growth of its Rare Neurology Franchise, focusing on ALS centers, providers, and key stakeholders.

You will communicate complex clinical data and guide patients through access programs to enable timely therapy initiation. The role emphasizes cross-functional collaboration, market access navigation, and education on disease pathways, with initial focus on FUS-ALS and related therapies, while